NCT00025220 2019-07-23
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
5 trialsNCT00004876 2013-08-26
Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006005 2013-06-21
Thalidomide in Treating Patients With Gynecologic Sarcomas
National Cancer Institute (NCI)
Phase 2 Completed
NCT00016224 2013-06-18
Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00025467 2013-01-24
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed